British Lung Foundation welcomes mesothelioma biomarker promise
This article was originally published in Clinica
Executive Summary
The British Lung Foundation (BLF) welcomed the publication today of research into a new mesothelioma biomarker – serum mesothelin – as "an important step forward" in diagnosing and treating the disease sooner, with the promise of lengthening survival time.